Technical Analysis for KZR - Kezar Life Sciences, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
B | 7.51 | 0.20% | 0.02 |
KZR closed up 1.49 percent on Wednesday, November 20, 2024, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Resistance | Bearish | 0.20% | |
Crossed Above 200 DMA | Bullish | 0.20% | |
Pocket Pivot | Bullish Swing Setup | 0.20% | |
Bollinger Band Squeeze | Range Contraction | 0.20% | |
NR7 | Range Contraction | 0.20% | |
Narrow Range Bar | Range Contraction | 0.20% | |
Inside Day | Range Contraction | 0.20% | |
20 DMA Resistance | Bearish | 1.69% | |
200 DMA Resistance | Bearish | 1.69% | |
50 DMA Support | Bullish | 1.69% |
Alert | Time |
---|---|
20 DMA Support | about 1 hour ago |
60 Minute Opening Range Breakdown | about 2 hours ago |
20 DMA Resistance | about 2 hours ago |
Rose Above Previous Day's High | about 4 hours ago |
Rose Above 20 DMA | about 4 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/13/2024
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Life Sciences Pharmaceutical Autoimmunity Molecule Therapeutics Immunity
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Life Sciences Pharmaceutical Autoimmunity Molecule Therapeutics Immunity
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 11.35 |
52 Week Low | 5.202 |
Average Volume | 115,454 |
200-Day Moving Average | 7.43 |
50-Day Moving Average | 7.31 |
20-Day Moving Average | 7.51 |
10-Day Moving Average | 7.45 |
Average True Range | 0.40 |
RSI (14) | 51.22 |
ADX | 22.31 |
+DI | 13.88 |
-DI | 12.00 |
Chandelier Exit (Long, 3 ATRs) | 7.25 |
Chandelier Exit (Short, 3 ATRs) | 8.05 |
Upper Bollinger Bands | 8.02 |
Lower Bollinger Band | 7.01 |
Percent B (%b) | 0.48 |
BandWidth | 13.46 |
MACD Line | -0.02 |
MACD Signal Line | 0.00 |
MACD Histogram | -0.0285 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 7.69 | ||||
Resistance 3 (R3) | 7.69 | 7.64 | 7.65 | ||
Resistance 2 (R2) | 7.64 | 7.59 | 7.63 | 7.64 | |
Resistance 1 (R1) | 7.56 | 7.56 | 7.60 | 7.56 | 7.63 |
Pivot Point | 7.51 | 7.51 | 7.53 | 7.50 | 7.51 |
Support 1 (S1) | 7.43 | 7.46 | 7.47 | 7.43 | 7.35 |
Support 2 (S2) | 7.38 | 7.43 | 7.37 | 7.34 | |
Support 3 (S3) | 7.30 | 7.38 | 7.33 | ||
Support 4 (S4) | 7.30 |